Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the plegridy market size evolved in recent years?
The market size of Plegridy has witnessed an XX (HCAGR) growth in the past recent years. The market is projected to surge from $XX million in 2024 to $XX million in 2025 with a Compound Annual Growth Rate (CAGR) of XX%. Factors contributing to this growth during the historical period include escalating healthcare spending, an upward trend in the incidence of relapsing-remitting multiple sclerosis, growing preference for self-managed treatment options, a heightened emphasis on patient compliance and a rise in the consumption of biologics.
What are the predictions for the plegridy market size in the coming years?
Over the coming years, the market size of Plegridy is anticipated to witness a future compound annual growth rate (FCAGR) of XX%. Predictions indicate that it has the potential to expand to a remarkable $XX million by 2029, with an expected compound annual growth rate (CAGR) of XX%. The projected growth within this period can be related to the increasing interest in personal medicine, advancements in healthcare at home, a greater use of digital health tools, an increasing aging population, and an expansion in insurance coverage. Noteworthy trends during this forecast period encompass the integration of digital health, the adoption of combination therapies, advancements in the delivery systems of drugs, the use of telemedicine, and the application of artificial intelligence in managing multiple sclerosis.
Get your plegridy market report here!
https://www.thebusinessresearchcompany.com/report/plegridy-global-market-report
What key factors are fueling the growth of the plegridy market?
The growth of the plegridy market going forward is forecasted to be influenced by the escalating prevalence of multiple sclerosis. This chronic autoimmune disorder entails the immune system erroneously attacking the myelin sheath that protects the nerve fibers in the central nervous system. Consequently, this disrupts communication between the brain and the body, leading to an array of neurological symptoms. The increasing incidence of multiple sclerosis is ascribed to an interplay of environmental elements, enhanced diagnostic methods, heightened disease awareness and recognition, and lifestyle modifications such as obesity and vitamin D deficiency, especially among women. Plegridy is employed in treating patients with multiple sclerosis to decrease relapse rates and modulate the immune system, thereby decelerating disease progression. For example, a report published by the Multiple Sclerosis Trust, a national charity organization based in the UK, noted in May 2024 that over 150,000 people in the UK are living with multiple sclerosis and the number of new diagnoses is rising annually by over 7,100. In addition, the incidence of multiple sclerosis has risen by up to 15% in various regions, most commonly diagnosing individuals in their 30s and 40s. Consequently, the surging prevalence of multiple sclerosis is contributing to the expansion of the plegridy market.
How is the global plegridy market divided into key segments?
The plegridy market covered in this report is segmented –
1) By Roue Of Administration: Subcutaneous (SC) Injection; Intramuscular (IM) Injection
2) By Clinical Indication: Relapsing-Remitting Multiple Sclerosis (RRMS); Secondary Progressive Multiple Sclerosis (SPMS) With Relapses
3) By Distribution Channel: Direct Sales; Online Pharmacies; Wholesale Distributors
4) By End User: Hospitals; Clinical Research Laboratories
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20332&type=smp
Who are the key firms paving the way for growth in the plegridy market?
Major companies operating in the plegridy market are Biogen Inc.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20332
What regions are contributing significantly to the growth of the plegridy market?
North America was the largest region in the plegridy market in 2024. The regions covered in the plegridy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Multiple Sclerosis Drugs Global Market Report 2025
https://thebusinessresearchcompany.com/report/multiple-sclerosis-drugs-global-market-report
Atherosclerosis Drugs Global Market Report 2025
https://thebusinessresearchcompany.com/report/atherosclerosis-drugs-global-market-report
Focal Segmental Glomerulosclerosis Drugs Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
